Haleon (NYSE:HLN) Raised to “Strong-Buy” at Hsbc Global Res

Haleon (NYSE:HLN) was upgraded by equities research analysts at Hsbc Global Res from a “hold” rating to a “strong-buy” rating in a research note issued on Wednesday,Zacks.com reports.

Several other analysts have also issued reports on the stock. Morgan Stanley restated an “overweight” rating on shares of Haleon in a research report on Monday, December 15th. Jefferies Financial Group reiterated a “buy” rating on shares of Haleon in a research note on Tuesday. Deutsche Bank Aktiengesellschaft lowered Haleon from a “hold” rating to a “sell” rating in a research note on Monday, January 12th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Haleon has a consensus rating of “Moderate Buy” and a consensus price target of $12.33.

Haleon Trading Up 0.8%

Haleon stock opened at $10.32 on Wednesday. The business has a 50-day simple moving average of $9.84 and a two-hundred day simple moving average of $9.61. Haleon has a 52-week low of $8.71 and a 52-week high of $11.42. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. The company has a market cap of $45.96 billion, a P/E ratio of 26.46 and a beta of 0.19.

Institutional Investors Weigh In On Haleon

A number of hedge funds have recently made changes to their positions in HLN. Hanson & Doremus Investment Management grew its holdings in Haleon by 234.1% during the 2nd quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock valued at $25,000 after buying an additional 1,662 shares in the last quarter. Golden State Wealth Management LLC boosted its position in shares of Haleon by 107.6% during the 2nd quarter. Golden State Wealth Management LLC now owns 2,721 shares of the company’s stock valued at $28,000 after acquiring an additional 1,410 shares during the last quarter. SOA Wealth Advisors LLC. grew its holdings in shares of Haleon by 60.5% in the third quarter. SOA Wealth Advisors LLC. now owns 3,105 shares of the company’s stock valued at $28,000 after purchasing an additional 1,170 shares in the last quarter. Citizens National Bank Trust Department grew its holdings in shares of Haleon by 167.4% in the third quarter. Citizens National Bank Trust Department now owns 3,276 shares of the company’s stock valued at $29,000 after purchasing an additional 2,051 shares in the last quarter. Finally, Hilltop National Bank bought a new stake in Haleon in the second quarter worth $33,000. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.